Boost

RADIATION6 trials

Sponsors

The Netherlands Cancer Institute, Centre Georges Francois Leclerc, UMC Utrecht, 424 General Military Hospital, NYU Langone Health

Conditions

Breast CancerEsophageal CancerHealthy SubjectsHypertensionRectal Cancerrectal tumor

Phase 2

Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus

CompletedNCT01348217

Centre Georges Francois LeclercEsophageal Cancer

Start: 2011-05-06End: 2018-12-17Updated: 2020-01-27

Phase 3

Radiation Dose Intensity Study in Breast Cancer in Young Women

The Netherlands Cancer InstituteBreast Cancer

Start: 2004-07-31End: 2025-12-31Target: 2400Updated: 2022-01-21

Unknown Phase

RECTAL BOOST Study

UMC UtrechtRectal Cancer

Start: 2014-09-01End: 2020-12-01Updated: 2019-09-25

Circulating Levels of Irisin in Healthy Young Subjects

CompletedNCT01986530

424 General Military HospitalHealthy Subjects

Start: 2013-11-30End: 2015-01-31Updated: 2015-01-22

BioXmark liquid fiducial to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial

Active, not recruitingNL-OMON47645

MAASTRO clinicrectal tumor

Start: 2018-02-02Target: 20Updated: 2024-02-28

Jackson Heart Study Women's Hypertension Study

RecruitingNCT06511479

NYU Langone HealthHypertension

Start: 2024-11-18End: 2027-05-30Target: 300Updated: 2026-02-25

Related Papers

Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study.

2024-01-043 citations

Impact of Dose-Escalated Chemoradiation on Quality of Life in Patients With Locally Advanced Rectal Cancer: 2-Year Follow-Up of the Randomized RECTAL-BOOST Trial.

2021-10-0814 citations

Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial.

2020-06-1958 citations

Exclusive chemoradiotherapy with or without dose escalation in locally advanced esophageal carcinoma: The CONCORDE study (PRODIGE 26).

Journal of Clinical Oncology2017-05-2011 citations

The impact of retractor SPONGE-assisted laparoscopic surgery on duration of hospital stay and postoperative complications in patients with colorectal cancer (SPONGE trial): study protocol for a randomized controlled trial.

2016-03-109 citations

Abstract P4-11-01: Factors influencing patient reported cosmetic outcome: Results of the Young Boost trial

Cancer Research2016-02-15

Phase II/III randomized trial of exclusive chemoradiotherapy with or without dose escalation in locally advanced esophageal carcinoma: The CONCORDE study (PRODIGE 26).

Journal of Clinical Oncology2016-02-017 citations

RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial.

2015-02-2253 citations